Novartis AG (NYSE:NVS).
Cgov Asset Management lowered its ownership in Novartis AG shares by 133,741 shares in its quarterly SEC filing. Its stake was valued at $93,568,000 a decrease of 5.2% according to the filing.
The following firms have also recently changed their position in NVS. As of the end of the quarter Pennsylvania Trust Co had acquired a total of 16,816 shares growing its position 25.3%. The value of the investment in (NVS) increased from $4,942,000 to $6,958,000 a change of 40.8% for the reporting period. As of quarter end Creative Planning had sold 3,148 shares trimming its holdings by 5.4%. The value in dollars went from $4,320,000 to $4,592,000 a change of $272,000 quarter over quarter.
Narwhal Capital Management expanded its investment by buying 1,950 shares an increase of 4.1% as of 06/30/2017. Narwhal Capital Management currently owns 49,960 shares worth $4,170,000. The total value of its holdings increased 16.9%.
On July 5 the stock rating was downgraded from “” to “Underperform” in a report issued by Credit Suisse. On November 10 the company was upgraded to “Buy” from “Hold” in a report from Argus Research.
Equity analyst Chardan Capital initiated coverage on the stock with an initial rating of “Buy” and projecting a price target of $95.00. On April 12 the stock rating was downgraded to “Underperform” from “Equal-weight” in a statement from Morgan Stanley.
On April 5 analysts at Argus Research added NVS to its research portfolio by announcing an initial rating of “Hold”. On April 1, 2016 the stock rating was changed to a “Neutral” according to a UBS report a cut from the previous “Buy” rating.
The company is trading up by 1.49% since yesterday’s close of $81.99. Novartis AG also recently declared a dividend paid on Thursday the 20th of April 2017. The dividend payment was $0.680 per share for the quarter which is $2.72 annualized. The dividend yield was $3.30. The ex-dividend date was set for Wednesday the 1st of March 2017.
It is currently trading at $83.21 which is marginally over $81.82, the stock’s 50 day moving average and which is just over the 200 day moving average of $76.18. The 50 day moving average was up by +1.69% and the 200 day average went up $7.03 or +9.23%.
Novartis AG currently has a P/E ratio of 31.28 and market capitalization is 196.84B. In the last earnings report the EPS was $2.66 and is expected to be $4.72 for the current year with 2,365,595,000 shares now outstanding. Next quarter’s EPS is forecasted at $1.21 with next year’s EPS projected to be $5.19.